100 participants
ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-08-31
- Start Date:
- 2022-01-24
- Completion:
- 2027-11-30
Conditions
- Advanced Lung Non-Small Cell Carcinoma
Interventions
- DIAGNOSTIC_TEST
No Results Yet